Patent Foramen Ovale Repair ProcedureDescription, Latest Information and Doctors
Learn About Patent Foramen Ovale Repair
Konstantinos Tsioufis practices practicing medicine in Athens, Greece. Mr. Tsioufis is rated as an Elite expert by MediFind in Patent Foramen Ovale Repair. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Hypertension, Coronary Heart Disease, Patent Foramen Ovale, Patent Foramen Ovale Repair, and Transcatheter Aortic Valve Replacement (TAVR).
MUSC Children's Health Cardiology At Summey Medical Pavilion
John Rhodes is a Cardiologist and a Pediatric Cardiologist practicing medicine in North Charleston, South Carolina. Dr. Rhodes is rated as a Distinguished provider by MediFind in Patent Foramen Ovale Repair. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Atrial Septal Defect (ASD), Patent Foramen Ovale, Pulmonary Atresia with Intact Ventricular Septum, Patent Foramen Ovale Repair, and Angioplasty. Dr. Rhodes is currently accepting new patients.
Anastasios Apostolos practices practicing medicine in Athens, Greece. Mr. Apostolos is rated as an Elite expert by MediFind in Patent Foramen Ovale Repair. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Patent Foramen Ovale, Atrial Septal Defect (ASD), Aortic Valve Stenosis, Patent Foramen Ovale Repair, and Transcatheter Aortic Valve Replacement (TAVR).
Summary: Patent foramen ovale (PFO) is a congenital interatrial communication present in about one quarter of the general population and is recognized as a major cause of cryptogenic stroke. Percutaneous PFO closure reduces recurrent stroke, but a residual right-to-left shunt persists in 20 to 40 percent of patients after device implantation. Long-term data on device performance, the evolution of residual ...
Summary: Patent foramen ovale PFO closure has been shown to reduce the risk of stroke in patients with recurrent stroke. However, the majority of existing clinical studies in this field excluded patients over the age of 60 years. Data in older patients is limited and since the population ages and stroke remains a major cause of death and morbidity, randomized clinical trials are needed to better assess the...